Ετικέτες

Παρασκευή 15 Σεπτεμβρίου 2017

Scholar : Ειδοποίηση Μελετητή - [ ΜΑΣΤΟ

Ειδοποίηση Μελετητή:[ ΜΑΣΤΟΕΙΔΙΤΙΣ ]

Outpatient management of pediatric acute mastoiditis

A Alkhateeb, F Morin, H Aziz, M Manogaran, W Guertin… - International Journal of …, 2017
Download PDF Opens in a new window. Article suggestions will be shown in a dialog on return
to ScienceDirect. ... Please enable JavaScript to use all the features on this page. ... Evaluate
the Montreal Children's Hospital experience with outpatient management of uncomplicated acute
Google+ Facebook Twitter

Bone Density Development of the Temporal Bone Assessed by Computed Tomography.

K Takahashi, Y Morita, S Ohshima, S Izumi, Y Kubota… - Otology & Neurotology, 2017
Hypothesis: The temporal bone shows regional differences
in bone development. Background: The sprea.
Google+ Facebook Twitter

[PDF] Tuberculosis in otolaryngological practice

GA Ghate, PS Chavan, J Thomas, MH Ingale - International Journal of …, 2017
... 2. Tuberculous mastoiditis The presenting complaints were chronic discharge not responding
to antibiotic therapy and variable degree of conductive hearing loss. ... Lupus vulgaris 4 1 5 19 Larynx
3 1 4 15 Otitis media/ mastoiditis 4 2 5 19 Pre auricular sinus 1 0 1 3 ...
Google+ Facebook Twitter

Update on the Management of Otitis Media

E Tignor, DY Bailey LeConte, T Makishima - Recent Advances in Pediatric Medicine: …, 2017
... Intratemporal complications (complications which remain confined to the ear) include common
complications such as tympanic membrane perforation which occurs in 7% of acute infections,
and rarer complications which include mastoiditis, labyrinthitis, vertigo, conductive or ...
Google+ Facebook Twitter

[PDF] Uso del test rápido de detección de antígeno estreptocócico en la consulta de Atención Primaria

SB Subiranaa, MC Salvadoresa, M Anna… - Rev Pediatr, 2017
... importancia de la identificación del Streptococcus pyogenes como agente etiológico de una
FAA radica en las posibles complicaciones que puede comportar: complicaciones supurativas
(1-2%) como otitis media, sinusitis aguda, absceso periamigdalino, mastoiditis o absceso ...
Google+ Facebook Twitter

[PDF] Microbes in acute otitis media in Finnish children

S Sillanpää - 2017
... 2013]. After all, myringotomy is sometimes needed if the causative bacteria must
be identified in severely ill patients, in mastoiditis or in patients with immunodeficiency
[Heikkinen et al. 2010]. Page 23. 21 2.3.3.2 Tympanometry ...
Google+ Facebook Twitter

[DOC] AGENTE PATÓGENO

M DE PROPAGACIÓN
... En 1936, André Lemierre dividió a los pacientes con septicemias anaerobias en 6 grupos, de
acuerdo con el origen de la infección: lesiones inflamatorias en nasofaringe, compromiso de
boca y mandíbula, otitis media o mastoiditis, endometritis purulenta posparto, apendicitis ...
Google+ Facebook Twitter

Mrmc Neo Surgical Ventilating Port and Neo Attic Malleo-Incudal Complex in Endoscopic Management of Limited Attico-Antral Cholesteatoma

CB Nandyal, M Sutrave, V Kurle, PA Harsoor - Indian Journal of Otolaryngology and Head & …
... middle ear. In: Flint WP et al (eds) Cummings otolaryngology head and neck surgery,
vol 3, 5th edn. Mosby Inc, Philadelphia, pp 1833–1842Google Scholar. 9. Proctor
B (1991) Chronic otitis media and mastoiditis. In: Paparella ...
Google+ Facebook Twitter

[HTML] Post Category→ Neurology

HP Brief - Imaging
... Lesion: Muscle Causes: Rhabdomyolysis, polymyositis, dermatomyositis, myopathies Findings:
Muscle tenderness to palpation, no UMN signs, no sensory disturbances Facial weakness, upper
and lower face Lesion: CNVII Causes: Bell's palsy, mastoiditis, parotitis Other CN ...
Google+ Facebook Twitter

Compositions and methods for treating chronic inflammation and inflammatory diseases

RM Bannister, J Brew, W Caparros-Wanderely, SJ Dilly… - US Patent 9,750,810, 2017
The present specification discloses pharmaceutical compositions, methods of preparing such
pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or
an inflammatory disease in an individual using such pharmaceutical compositions.
Google+ Facebook Twitter


Αυτή η Ειδοποίηση του Μελετητή Google σας προσφέρεται από τη Google

Ακύρωση ειδοποίησης
Δημιουργία λίστας των ειδοποιήσεών μου


Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αναζήτηση αυτού του ιστολογίου